Insider Transactions in Q1 2024 at Anika Therapeutics, Inc. (ANIK)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 11
2024
|
Michael L Levitz EVP, CFO, Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,638
-4.26%
|
$140,950
$25.54 P/Share
|
|
Mar 11
2024
|
Michael L Levitz EVP, CFO, Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,201
+12.62%
|
-
|
|
Mar 11
2024
|
Anne Nunes SVP, Chief Operations Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,720
-7.9%
|
$43,000
$25.61 P/Share
|
|
Mar 11
2024
|
Anne Nunes SVP, Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,856
+21.06%
|
-
|
|
Mar 11
2024
|
David Colleran EVP, General Counsel, Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
4,936
-5.41%
|
$123,400
$25.54 P/Share
|
|
Mar 11
2024
|
David Colleran EVP, General Counsel, Corp Sec |
BUY
Exercise of conversion of derivative security
|
Direct |
16,809
+15.52%
|
-
|
|
Mar 11
2024
|
Cheryl R Blanchard President, CEO, Director |
SELL
Payment of exercise price or tax liability
|
Direct |
27,980
-6.22%
|
$699,500
$25.54 P/Share
|
|
Mar 11
2024
|
Cheryl R Blanchard President, CEO, Director |
BUY
Exercise of conversion of derivative security
|
Direct |
64,480
+12.54%
|
-
|